About Stembio
Stembio is a company based in Istanbul (Turkey) founded in 2020 was acquired by Koc Holding in September 2024. Stembio offers products and services including EXOSTEM, STEMBIOCELL, STEMCORD, STEMTISSUE, and STEMANIMA. Stembio operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Istanbul, Turkey
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Koc Holding
(Sep 20, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stembio
Stembio offers a comprehensive portfolio of products and services, including EXOSTEM, STEMBIOCELL, STEMCORD, STEMTISSUE, and STEMANIMA.
Provides exosomes from stem cells for medical treatments.
Produces and banks cellular products for therapies.
Handles autologous and allogeneic cord blood storage.
Manages human tissue grafts for medical applications.
Offers tissue and cellular products for animal treatments.
Provides products for esthetic and skin regeneration.
Delivers gene-based treatments for health conditions.
Supplies devices and services for regenerative applications.
Funding Insights of Stembio
Detailed funding history for Stembio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Stembio
Stembio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Koc Holding.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are managed across energy, automotive, and finance sectors.
|
Locked | Locked | Locked |
Investor details for Stembio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stembio
Investment portfolio details for Stembio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stembio
Detailed financials for Stembio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stembio Comparisons
Peer comparison for Stembio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stembio
Stembio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| Locked | Locked | Locked |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Detailed competitors of Stembio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stembio
Complete news archive for Stembio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stembio
Stembio was founded in 2020.
Stembio is headquartered in Istanbul, Turkey.
Stembio was established in 2020 in Istanbul, Turkey, within the biotechnology sector focused on regenerative medicine. Human-derived cells and tissues are processed through specialized methods, including cryopreservation and quality control. Products are stored for accessibility and formatted for clinical applications. Services encompass cellular therapies, cord blood banking, tissue grafts, exosomes from mesenchymal stem cells, gene therapies, and aesthetic treatments.
Stembio's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Stembio offers EXOSTEM, STEMBIOCELL, STEMCORD, STEMTISSUE, and 4 more products and services.
Stembio has 1 investor. Key investors include Koc Holding.